Life Science Players
For organizations ready to bring rare disease therapies to market from clinical stage (Phase II/III)
Our platform is made for organizations ready to bring rare disease therapies to market from clinical stage, including Pharmaceutical Companies, Foundations, Governments, Venture Capital, Private Equity, Family Offices, Insurance Companies, and Sovereign Funds.
Why license medical product candidates from Shrare?
Advanced clinical-stage opportunities with comprehensive market intelligence and execution support
What You Get
- Advanced clinical-stage medical product candidates
- Optimal R&D strategy, IP protection & marketing exclusivities
- Comprehensive financial modeling (cost to approval, revenue projections)
- Risk analysis with clinical success predictions
- Ready-to-execute network (researchers, KOLs, manufacturers, patient associations)
- Wide choice of diseases, organs, and technologies
- AI-powered due diligence platform for faster decision-making
Business Impact
Higher ROI
Maximize return on investment with pre-validated opportunities and comprehensive market intelligence
Streamlined Execution
Reduce approval complexity with ready networks, regulatory strategies, and expert support
A New Era in Pharma.
SHRARE is where science meets scale, and collaboration meets velocity.
Just like Uber transformed mobility, and Airbnb reimagined hospitality, SHRARE is building the first global sharing platform for rare-disease innovation.
But instead of rides or rooms, we connect clinical-stage research with the pharma, foundations, and institutions ready to bring it to life. We're not just a marketplace — we're building the pharma ecosystem of the future.
One that is collaborative. Digital. Borderless. Human-first.
Be First in Line.
No cost. No obligation. Just first access to what's next.
We're opening the doors to a curated portfolio of the most promising medical product candidates for rare diseases. Early access gives you unmatched insight and priority connection—before the public launch.
Early-Access Advantages
Shape the Platform
Your input helps define the therapies and fields we prioritize
Stay Ahead
Be the first to receive targeted candidates aligned with your pipeline strategy
Exclusive Rights
Priority review and direct negotiation channels before the marketplace goes public
Join a new kind of pharmaceutical movement — open, tech-driven, and researcher-aligned.Work alongside next-generation scientists, co-develop therapies, and stay ahead of the curve.
This is more than early access.
It's your entry point into a new kind of pharma.
No commitment required — just share your interests and help shape the future.
Frequently Asked Questions
Everything you need to know about joining our marketplace
Why should I register before the marketplace is fully launched?
What information do you need about our interests?
What happens at 30 medical product candidates?
What makes Shrare different from other platforms?
Ready to Make a Difference?
Join us in our mission to save lives. Register now and be a part of a community dedicated to transforming rare disease research into life-saving treatments.